In 2016, the global infection control market was valued at USD 150.4 million. It is expected to grow at 6.2% CAGR over the forecast period. This market is primarily driven by the increasing number of surgical procedures that involve high-intensity infection prevention. Positive clinical outcomes associated to infection control are believed to explain the high preference.
U.S. Infection Control Market by Type, 2014-2025 (USD Billion).
Market growth is expected to be driven by the increasing number of government initiatives that aim to prevent high-degree infection. Market growth is expected to be driven by the increasing involvement of government agencies in the development of guidelines to increase awareness about effective prevention measures worldwide.
The World Health Organization (WHO), for instance, has published guidelines to prevent and control pandemic- or epidemic-prone acute respiratory disease in healthcare. These guidelines cover everything from hand hygiene and the use of personal protection to sterilization and disinfection.
Acute Respiratory Disorders (ARDs), according to WHO statistics, are one of the leading causes of high mortality rates worldwide. Acute Respiratory Diseases (ARDs) are responsible for approximately 4.0 million deaths each year. These statistics are a good example of the need to have strict prevention and control.
Majority of hospital-acquired infections are caused by diseases such as pneumonia, bloodstream, urinary tract, and surgical site infections. Other major hospital-acquired infections (HAI) include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstreams. HAI is a concern that can affect patient recovery and have a significant impact on global mortality rates.
A WHO practical guide on how to prevent HAI was published. It found that the average increase in hospitalization time for surgical infections is approximately 8 days. This is a major contributor to hospitalization costs and raises the need for infection prevention measures.
As a result of the excessive use of resources to treat acquired infections, it is likely that prolonged hospital stays are not economically feasible for both the hospitals and the healthcare payers. This is mainly due to increased use of drugs, additional diagnostic tests, and laboratory equipment. It creates an imbalance in resource allocation.
Consumables made up the largest portion of the type segment in 2016. Consumables are expected to hold the majority of the type segment's share due to their consistent use and short life cycles. Consumables are increasingly being used in sterilization, sterilization, and other control procedures. This accounts for a greater share.
Personal protective equipment accounted for a significant portion of 2016 consumables. Many healthcare organizations have been promoting personal protective equipment and advocating for their benefits. This is expected to account for a large portion of the 2016 consumables market. In 2014, for example, the WHO released guidelines that included strategies and recommendations regarding personal protective equipment.
These organizations strive to encourage the adoption by issuing guidelines and recommendations regarding selection, risk assessment rational usage, removal, and considerations to reduce the risk to respiratory pathogens being transmitted to healthcare workers.
Services are predicted to grow at a profitable rate over the forecast period in this type segment. Market players are inclined to lower healthcare costs and maximize benefits. This is why this segment is expected to grow at the fastest rate. It includes cost savings, improved efficiency of services, and a much higher focus on core areas of development which are crucial to a company’s overall profit and growth.
In 2016, hospitals held a dominant position with a large share of the end-use segment. They are expected to grow at the fastest CAGR during the forecast period. This large share is mainly due to the high likelihood of infection in hospitals through bloodborne or respiratory pathogen transmission.
HAIs pose a major challenge and require strict control. Hospitals and public health agencies have been urged to implement highly efficient control systems. According to research published by NCBI, 40-60% of hospital infections are thought to originate from surgical sites.
Market share of global infection control, by end-use, 2016, (%)
One of the main concerns is the high risk of infection by bloodborne pathogens and drug-resistant pathogens. UTIs can be caused by frequent use of urinary catheters. According to NCBI research, 25% of all bacterial infection are caused by UTIs.
According to the National Nosocomial Illness Surveillance (NNIS), most hospital-acquired UTIs can be linked to catheterization. CA-bacteriuria, which accounts for as much as 40% of all HAIs in the U.S. each and every year, is the most common HAI worldwide. These factors will increase the market's future growth potential.
North America held a dominant market share in 2016. This region is believed to have a greater market share because of the consistent collaborations that key market players have made to expand their product ranges and improve their infection control capabilities.
North America holds the largest share of the region's captured market. This is due to the increased efforts of established companies to expand their presence in this region. Advanced Sterilization Products, for example, launched the STERRAD 100NX system with ALLClear in January 2017. It plans to expand its presence into other regions, such as Europe, Africa and the Middle East.
Due to increasing healthcare spending, the increased presence of outsourcing companies, and the unprecedented development of healthcare infrastructure in this region, the Asia Pacific market will experience the highest CAGR over the forecast period. One of the key factors driving the Asia Pacific region's growth is the presence of many voluntary and government organizations that work to improve infection control standards.
The market is also being driven by the increasing trend of outsourcing from established market players in developed countries to companies in Asia Pacific. The Asia Pacific Society of Infection Control is a non-profit organization that works to establish collaborative partnerships in order to improve quality and promote cost-efficient practices across the region.
Major companies like Cantel Medical Corporation and Advanced Sterilization Products have extensive collaboration strategies that are driving the competition. This is what accounts for their dominating market share. These companies are focused on implementing competitive strategies, such as mergers and acquisitions, new product development initiatives and geographic expansion.
In March 2017, 3M and Kimberly-Clark Health Care formed an alliance to jointly develop and deliver surgical and infection prevention strategies using their respective expertise. Although the details of the deal are not known, they will likely be implemented before the end 2017.
In July 2016, 3M also launched a 4-hour rapid-readout biological indicator for the vaporized hydrogen peroxide staining process. It was designed to provide results within 4 hours and monitor steam sterilization loads. This product was launched by the company to expand its product line.
This report predicts revenue growth at the global, regional and country levels. It also analyzes the industry trends for each sub-segment from 2014 to 2025. Grand View Research has divided the global infection control market based on type, end-use, and location.
Type Outlook (Revenue, USD Billion, 2014 - 2025)
Equipment
Disinfectors
Washers
Flushers
Endoscope Reprocessors
Sterilization equipment
Heat Sterilization Equipment
Low Temperature Sterilization Equipment
Radiation Sterilization Equipment
Filtration Sterilization Equipment
Liquid Sterilization Equipment
Other
Services
Contract Sterilization
Ethylene Oxide Sterilization
E-beam Sterilization
Gamma Sterilization
Other
Infectious Waste Disposal
Consumables
Infectious Waste Disposal
Disinfectants
Sterilization Consumables
Protective equipment for the personal
Other
End-use Outlook (Revenue, USD Billion, 2014 - 2025)
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Companies
Other
Regional Outlook (Revenue USD Billion, 2014-2025)
North America
The U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Mexico
Brazil
Middle East & Africa
South Africa
b. Global infection control market was valued at USD 178.75 Billion in 2019, and is projected to grow to USD 189.65 Billion by 2020.
What is the growth rate of the infection control market?b. Global infection control market will grow at 6.2% compound annual growth rate from 2018 to 2025, to reach USD 258.28 trillion by 2025.
Which segment had the largest share of infection control market?b. With a 34.48% share in 2019, North America was the dominant market for infection control. This is due to the increasing number of surgeries that require high-intensity infection prevention.
What are the major players in the infection control market?b. The market for infection control is dominated by 3M Company, Belimed AG, Halyard Health, Inc., Getinge Group, Advanced Sterilization Products, Matchana Group, Sterigenics Interna, MMM Group, Cantel Medical Corporation, STERUS Corporation.
What are the driving factors for the infected control market?b. The market is driven by a rising number of government initiatives that ensure high-level infection prevention.
Up Market Research published a new report titled “Infection Control Market research report which is segmented by Type (Services, Sterilization Equipment, Disinfectors, Consumables, Equipment), By Players/Companies 3M Company, MMM Group, Cantel Medical Corporation, Sterigenics International, Advanced Sterilization Products, Inc, Getinge Group, STERUS Corporation, Belimed AG, Matchana Group, Halyard Health”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Infection Control Market Research Report |
By Type | Services, Sterilization Equipment, Disinfectors, Consumables, Equipment |
By Companies | 3M Company, MMM Group, Cantel Medical Corporation, Sterigenics International, Advanced Sterilization Products, Inc, Getinge Group, STERUS Corporation, Belimed AG, Matchana Group, Halyard Health |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 231 |
Number of Tables & Figures | 162 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type (Services, Sterilization Equipment, Disinfectors, Consumables, Equipment).
Infection Control Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Infection Control Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Infection Control Market Report:
Some other reports from this category!